National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Fructosuria is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Essential Fructosuria
- Hepatic Fructokinase Deficiency
- Ketohexokinase Deficiency
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Diabetes, Insulin-Dependent
Fructosuria is a rare but benign inherited metabolic disorder. It is characterized by the excretion of fruit sugar (fructose) in the urine. Normally, no fructose is excreted in the urine. This condition is caused by a deficiency of the enzyme fructokinase in the liver. This enzyme is needed for the synthesis of glycogen (the body's form of stored energy) from fructose. The presence of fructose in the blood and urine may lead to an incorrect diagnosis of diabetes mellitus.
Fructosuria is characterized by the presence of fructose in the urine. There are no other symptoms. However, the fructose may be mistaken for glucose (blood sugar) leading to an incorrect diagnosis of Diabetes Mellitus.
Fructosuria is a rare hereditary disorder transmitted as an autosomal recessive trait. The defective gene has been mapped to the Gene Map Locus 2p23.3-p23.2. Chromosomes, which are present in the nucleus of human cells, carry the genetic characteristics of each individual. Pairs of human chromosomes are numbered from 1 through 22, with an unequal 23rd pair of X and Y chromosomes for males, and two X chromosomes for females. Each chromosome has a short arm designated as "p" and a long arm identified by the letter "q". Chromosomes are further subdivided into many bands that are numbered. For example, chromosome 2p23.3 refers to band 23 on the short arm of chromosome 2.
Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.
All individuals carry 4-5 abnormal genes. Parents who are close relatives (consanguineous) have a higher chance than unrelated parents to both carry the same abnormal gene, which increases the risk to have children with a recessive genetic disorder.
Fructosuria affects about 1 out of every 130,000 persons in the United States. It affects males and females in equal numbers.
Comparison of the following disorder with Fructosuria may be useful for a differential diagnosis:
Diabetes Mellitus is a common disorder in which the body does not produce enough insulin and is, therefore, unable to convert nutrients into the energy necessary for daily activity. The disorder affects females and males approximately equally. Although the causes of Insulin-Dependent Diabetes are not known, genetic factors seem to play a role. Symptoms of Diabetes Mellitus can be very debilitating if left untreated, whereas Fructosuria does not cause excessive thirst, weight loss or fatigue. (For more information, choose "Diabetes" as your search term in the Rare Disease Database.)
Diagnosis of Fructosuria is made by testing the urine for the presence of fructose. Fructosuria does not require treatment as the symptoms are harmless.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:444-45.
Gitzelmann R, Steinmann B, Van den Berghe G. In: Scriver CR, Beaudet AL, Sly WS, et al. Eds. The Metabolic Molecular Basis of Inherited Disease. 7th ed. McGraw-Hill Companies. New York, NY; 1995:905-34.
Kozak M, Hayward B, Borek D, et al. Expression, purification and preliminary crystallographic studies of human ketohexokinase. Acta Crystallogr D Biol Crystallogr. 2001;57:586-88.
Boesiger P, Buchli R, Meier D, et al. Changes in liver metabolite concentrations in adults with disorders of fructose metabolism after intravenous fructose by 31P magnetic resonance spectroscopy. Pediatr Res. 1994;36:436-40.
Bonthron DT, Brady N, Donaldson IA, et al. Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase). Hum Mol Genet. 1994;3:1627-31.
Froesch ER. Disorders of fructose metabolism. 1976;5:599-611.
FROM THE INTERNET
McKusick VA, Ed. Online Mendelian Inheritance in Man (OMIM). The Johns Hopkins University. Entry Number; 229800: Last Edit Date; 11/1/1996.
Fructose Metabolism. nd. 4pp.
Monosaccharides and interconversion of sugars. Lecture 21. Dated: September 23, 2002:7pp.
Benign Fructosuria. PEDBASE. Last Updated: 8/01/1994:2pp.
CLIMB (Children Living with Inherited Metabolic Diseases)
176 Nantwich Road
Crewe, CW2 6BG
NIH/National Institute of Diabetes, Digestive & Kidney Diseases
Office of Communications & Public Liaison
Bldg 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 9/17/2007
Copyright 1988, 1989, 2003, 2007 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.